Cargando…
Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors
Psoriatic arthritis (PsA) is a chronic and painful inflammatory immune-mediated disease. It affects up to 40% of people with psoriasis and it is associated with several comorbidities such as obesity, diabetes, metabolic syndrome, and hypertension. PsA is difficult to diagnose because of its diverse...
Autores principales: | Makos, Anaïs, Kuiper, J. H., Kehoe, O., Amarasena, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957889/ https://www.ncbi.nlm.nih.gov/pubmed/36508130 http://dx.doi.org/10.1007/s10787-022-01092-x |
Ejemplares similares
-
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?
por: Curry, Philippa D. K., et al.
Publicado: (2022) -
IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
por: Iwaszko, Milena, et al.
Publicado: (2021) -
Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
por: Michelon, Melissa A, et al.
Publicado: (2010) -
Biomarkers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review
por: Magee, Conor, et al.
Publicado: (2021) -
TNF polymorphisms are associated with the development of joint erosions in psoriatic arthritis
por: Kane, D, et al.
Publicado: (2003)